Santhera Pharmaceuticals Holding AG (SANN) — Long-term Investment Intensity
Santhera Pharmaceuticals Holding AG (SANN) has a Long-term Investment Intensity of 0.7% as of June 2019. Long-term investments of CHF712.00K represent 0.7% of total assets of CHF106.09 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Santhera Pharmaceuticals Holding AG net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Santhera Pharmaceuticals Holding AG Long-term Investment Intensity (2014–2018)
This chart shows how Santhera Pharmaceuticals Holding AG's Long-term Investment Intensity has evolved across 5 annual periods from 2014 to 2018. As of June 2019, the intensity stands at 0.7%, reflecting long-term investments of CHF712.00K against total assets of CHF106.09 Million CHF. Also explore Santhera Pharmaceuticals Holding AG (SANN) total assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Santhera Pharmaceuticals Holding AG (2014–2018)
The table below presents the year-by-year Long-term Investment Intensity for Santhera Pharmaceuticals Holding AG from 2014 to 2018, covering 5 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market cap of Santhera Pharmaceuticals Holding AG.
| Year | LT Investment Intensity | LT Investments (CHF) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2018 | 0.6% | CHF690.00K | CHF110.29 Million | ▼ 0.0 pp |
| 2017 | 0.6% | CHF713.00K | CHF109.78 Million | ▲ +0.4 pp |
| 2016 | 0.3% | CHF270.00K | CHF90.79 Million | ▲ +0.1 pp |
| 2015 | 0.2% | CHF190.00K | CHF117.15 Million | ▼ -0.2 pp |
| 2014 | 0.4% | CHF85.00K | CHF22.95 Million | — |